These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12874361)

  • 1. Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.
    Lynch JM; Briles DE; Metzger DW
    Infect Immun; 2003 Aug; 71(8):4780-8. PubMed ID: 12874361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
    Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW
    Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
    Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
    Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
    PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines.
    Buchanan RM; Briles DE; Arulanandam BP; Westerink MA; Raeder RH; Metzger DW
    Vaccine; 2001 Feb; 19(15-16):2020-8. PubMed ID: 11228373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
    Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA
    Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage.
    Sun K; Johansen FE; Eckmann L; Metzger DW
    J Immunol; 2004 Oct; 173(7):4576-81. PubMed ID: 15383591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J; Dai W; Wang Z; Chen B; Li Z; Fan X
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
    Ohori J; Iuchi H; Maseda Y; Kurono Y
    Vaccine; 2020 Jan; 38(3):699-704. PubMed ID: 31668823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
    Jakobsen H; Bjarnarson S; Del Giudice G; Moreau M; Siegrist CA; Jonsdottir I
    Infect Immun; 2002 Mar; 70(3):1443-52. PubMed ID: 11854231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
    Jakobsen H; Saeland E; Gizurarson S; Schulz D; Jónsdóttir I
    Infect Immun; 1999 Aug; 67(8):4128-33. PubMed ID: 10417183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
    Vintiñi EO; Medina MS
    BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunity induced by pneumococcal glycoconjugate.
    Lee CJ; Lee LH; Gu XX
    Crit Rev Microbiol; 2005; 31(3):137-44. PubMed ID: 16170904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
    Hvalbye BK; Aaberge IS; Løvik M; Haneberg B
    Infect Immun; 1999 Sep; 67(9):4320-5. PubMed ID: 10456869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates.
    Zhang Q; Arnaoutakis K; Murdoch C; Lakshman R; Race G; Burkinshaw R; Finn A
    Pediatr Infect Dis J; 2004 Apr; 23(4):307-13. PubMed ID: 15071283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.